Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening method to test their effectiveness inside cells.
For the first time, scientists have identified promising drug candidates that irreversibly bind to a notoriously "undruggable" cancer protein, effectively and permanently disabling it.
Transcription factors, proteins that act as master regulators of gene expression, play a critical role in cancer development. Despite years of effort, designing small-molecule drugs to block these proteins has proven largely ineffective. As a result, researchers have recently turned their attention to peptides, short chains of amino acids, as a potential solution for targeting these elusive proteins.
Now, a team from the University of Bath has developed a breakthrough method to discover peptides that can selectively and irreversibly bind to transcription factors inside cells. Using this approach, they have successfully blocked a key cancer-driving transcription factor known as cJun, marking a significant step forward in targeting previously untreatable cancer mechanisms.
The team, publishing in the journal Advanced Science, used a new drug discovery screening platform technology, called the Transcription Block Survival (TBS) assay, which tests a huge number of peptides to "switch off" transcription factors that drive cancer.
Their previous work identified reversible inhibitors of cJun, but this latest work builds on that by discovering peptides that bind selectively and irreversibly within cells, permanently blocking cJun action.
How the Inhibitor Works
The transcription factor cJun has two identical halves, which bind on either side of the DNA strand to alter gene expression.
It can become overactive in cancer, driving uncontrolled cell growth, so the researchers designed a peptide inhibitor that binds to one-half of cJun, stopping it from forming pairs and attaching to the DNA.
Once they had made a peptide that bound to the transcription factor, the researchers modified it to bind irreversibly.
Dr Andy Brennan, first author of the study and Research Fellow in the University of Bath's Department of Life Sciences, said: "The inhibitor works a bit like a harpoon that fires across to the target and won't let go – it grips the cJun tightly and stops it from binding to the DNA.
"We'd previously identified reversible inhibitors but this is the first time we've managed to block a transcription factor irreversibly with a peptide inhibitor."
Testing and Screening with the TBS Assay
For the Transcription Block Survival assay, researchers inserted binding sites for cJun, into an essential gene in cells grown in the lab. As cJun binds to the gene, it prevents it from working and the cell dies. In contrast, if cJun is blocked by the peptide inhibitor, the gene activity is restored and the cell survives.
Jody Mason, CSO of Revolver Therapeutics and Professor of Biochemistry in the University of Bath's Department of Life Sciences, said: "Many drug candidates that are effective in vitro turn out to be toxic or don't penetrate cancer cells at all.
"However our platform screens for peptide activity directly in the cell, overcoming many common challenges faced by drugs based on small molecules or antibodies.
"The screen checks the activity of the inhibitor in a real cell environment which includes proteases and other proteins that can sometimes interfere with peptide activity, whilst also checking toxicity.
"We hope this technology can in the future uncover other promising drug candidates for previously 'undruggable' targets."
Having proven cell permeability and activity in cancer cells, as well as target selectivity, the researchers now need to show the inhibitors work in preclinical cancer models.
Reference: "An Intracellular Peptide Library Screening Platform Identifies Irreversible Covalent Transcription Factor Inhibitors" by Andrew Brennan, Scott Lovell, Keith W Vance and Jody M Mason, 17 March 2025, Advanced Science.
DOI: 10.1002/advs.202416963
The research was partly funded by the Medical Research Council and Biotechnology and Biological Sciences Research Council.
News
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
Multifunctional Nanogels: A Breakthrough in Antibacterial Strategies
Antibiotic resistance is a growing concern - from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa. Recently published in Angewandte Chemie, the study [...]
Nanoflowers rejuvenate old and damaged human cells by replacing their mitochondria
Biomedical researchers at Texas A&M University may have discovered a way to stop or even reverse the decline of cellular energy production—a finding that could have revolutionary effects across medicine. Dr. Akhilesh K. Gaharwar [...]
The Stunning New Push to Protect the Invisible 99% of Life
Scientists worldwide have joined forces to build the first-ever roadmap for conserving Earth’s vast invisible majority—microbes. Their new IUCN Specialist Group reframes conservation by elevating microbial life to the same urgency as plants and [...]
